Moleculin Biotech, Inc.
MBRX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001659617
In the last 90 days, Moleculin Biotech, Inc. insiders filed 3 open-market purchases and 0 sales; 18 institutions reported holding it in 13F filings for Q2 2026, worth $518.5K in total; no superinvestor holds it.
Holders of 5% or more of MBRX
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Moleculin Biotech, Inc., largest stake first. The change is against the holder's previous filing.
No holder currently reports owning 5% or more of Moleculin Biotech, Inc. on Schedule 13D or 13G.
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
3 Schedule 13D and 13G filings on Moleculin Biotech, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Aug 14, 20259:13 PM ET | Armistice Capital, LLCand 1 other | 13G/A | 4.99%1.59M shares | −3.94 ppfrom 8.93%Below 5% | Jun 30, 2025 | SEC |
| May 15, 20253:30 PM ET | Armistice Capital, LLCand 1 other | 13G/A | 8.93%1.25M shares | −1.06 ppfrom 9.99% | Mar 31, 2025 | SEC |
| Feb 14, 20255:51 PM ET | Armistice Capital, LLCand 1 other | 13G/A | 9.99%339.8K shares | – | Dec 31, 2024 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Moleculin Biotech, Inc. shares.
No Form 144 notices for Moleculin Biotech, Inc. are on file.